James Anderson, DPM
Foot & Ankle Surgery · Franklin, MANPI 1821075904
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Integra Lifesciences Corporation at 53.4% of the total. 2025 is the largest year on record at $1,758, more than ten times the $86 reported in 2019.
Across 88 payments — averaging $46.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Smith+Nephew$373
- Mimedx Group, Inc.$364
- Averitas Pharma Inc.$273
- Paratek Pharmaceuticals, Inc.$174
- Zimmer Biomet$121
- plus $587 from 15 others
What the payments were for
- Food & beverage$1,97649%
- Other$2,08951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 13 | $2,171 |
| Smith+Nephew | 17 | $373 |
| Mimedx Group, Inc. | 12 | $364 |
| Averitas Pharma Inc. | 9 | $273 |
| Paratek Pharmaceuticals, Inc. | 8 | $174 |
| Zimmer Biomet | 3 | $121 |
| Orthofix Medical, Inc. | 4 | $119 |
| AbbVie | 4 | $84 |
| Bioventus LLC | 4 | $64 |
| Bone Support Inc. | 1 | $46 |
| Amgen | 2 | $36 |
| Medtronic | 2 | $36 |
| Treace Medical Concepts, Inc. | 1 | $35 |
| Vertex | 1 | $31 |
| EBI, LLC | 1 | $27 |
| Solventum Corporation | 1 | $23 |
| Baudax Bio Inc. | 1 | $22 |
| Reprise Biomedical, Inc. | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Triad Life Sciences Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACell$858
- AMNIOEXCEL PLUS$679
- AMNIOEXCEL$552
How this compares
$4,065 in reported general payments places this provider in the 70th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 38 | $374 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Franklin
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Richard BakerHyannis$16K
- Mark SlovenkaiWaltham$14K
- Jaeyoung KimBoston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.